{
    "pmcid": "9000494",
    "qa_pairs": {
        "How does the CeVICA platform contribute to the selection of nanobodies against the SARS-CoV-2 spike protein?": [
            "It integrates a synthetic Nb library with ribosome display and computational clustering to identify binders.",
            "It uses a high-throughput screening method to rapidly test thousands of nanobody candidates.",
            "It employs a machine learning algorithm to predict the binding affinity of nanobodies.",
            "It combines phage display with deep sequencing to enhance the diversity of selected nanobodies."
        ],
        "What are the key advantages of using synthetic nanobody libraries over immune libraries?": [
            "Synthetic libraries avoid animal use, have shorter development times, and can target non-immunogenic or toxic antigens.",
            "Synthetic libraries require less computational resources and have higher throughput screening capabilities.",
            "Synthetic libraries are more cost-effective and have a higher yield of nanobodies per experiment.",
            "Synthetic libraries produce nanobodies with inherently higher stability and solubility than immune libraries."
        ],
        "What challenge is associated with synthetic nanobody libraries compared to immune libraries?": [
            "Synthetic libraries require large sizes to ensure sufficient diversity.",
            "Synthetic libraries have a higher risk of cross-reactivity with non-target antigens.",
            "Synthetic libraries are more prone to degradation during storage.",
            "Synthetic libraries often produce nanobodies with lower solubility."
        ],
        "What is the primary target of nanobodies designed for therapeutic and diagnostic applications against COVID-19?": [
            "The SARS-CoV-2 spike protein.",
            "The nucleocapsid protein of SARS-CoV-2.",
            "The membrane protein of SARS-CoV-2.",
            "The envelope protein of SARS-CoV-2."
        ],
        "What role does CDR3 play in the design of synthetic nanobody libraries?": [
            "CDR3 is the most variable region and plays a significant role in antigen recognition.",
            "CDR3 is the least variable region and provides structural stability to the nanobody.",
            "CDR3 is responsible for the solubility and stability of the nanobody.",
            "CDR3 determines the expression yield of the nanobody in various systems."
        ]
    }
}